Biofrontera Inc. - stock earnings
BFRI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 3.5 million USD | 10.6 million USD |
| 2023Q3 | -6.3 million USD | 8.9 million USD |
| 2023Q2 | -9.8 million USD | 5.8 million USD |
| 2023Q1 | -7.5 million USD | 8.7 million USD |
| 2022Q4 | -2.8 million USD | 10.1 million USD |
| 2022Q3 | -2.6 million USD | 4.3 million USD |
| 2022Q2 | 7.1 million USD | 4.5 million USD |
| 2022Q1 | -14.5 million USD | 9.2 million USD |
| 2021Q4 | -14.5 million USD | 9.2 million USD |
| 2021Q3 | -16.0 million USD | 4.3 million USD |
| 2021Q2 | -3.7 million USD | 5.9 million USD |
| 2021Q1 | -3.5 million USD | 4.7 million USD |
| 2020Q4 | -186000 USD | 8.6 million USD |
| 2020Q3 | -3.0 million USD | 3.3 million USD |
BFRI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -20.1 million USD | 34.1 million USD |
| 2022 | -640000 USD | 28.7 million USD |
| 2021 | -37.7 million USD | 24.1 million USD |
| 2020 | -11.0 million USD | 18.8 million USD |
| 2019 | -11.0 million USD | 26.2 million USD |
BFRI
Price: $1.78
52 week price:
Earnings Per Share: -13.02 USD
P/E Ratio: -0.03
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 345400
Market Capitalization: 9.3 million